Publications

Quality of care for secondary cardiovascular disease prevention in 2009- 2017: population-wide cohort study of antiplatelet therapy use in Scotland

PREISS D. et al, (2023), BMJ Quality and Safety

Impact of diabetes on the effects of sodium glucose co-transporter-2 inhibitors on kidney outcomes: collaborative meta-analysis of large placebo-controlled trials.

Nuffield Department of Population Health Renal Studies Group None. and SGLT2 inhibitor Meta-Analysis Cardio-Renal Trialists' Consortium None., (2022), Lancet, 400, 1788 - 1801

Empagliflozin in Patients with Chronic Kidney Disease.

EMPA-KIDNEY Collaborative Group None. et al, (2022), N Engl J Med

Population-wide cohort study of statin use for the secondary cardiovascular disease prevention in Scotland in 2009-2017.

Thalmann I. et al, (2022), Heart

Effect of statin therapy on muscle symptoms: an individual participant data meta-analysis of large-scale, randomised, double-blind trials.

Cholesterol Treatment Trialists' Collaboration None., (2022), Lancet, 400, 832 - 845

Individual participant data meta-analysis of muscle symptoms in large-scale randomised double-blind trials of statin therapy

BAIGENT C. et al, (2022), The Lancet

Harmonisation of large-scale, heterogeneous individual participant adverse event data from randomised trials of statin therapy.

Cholesterol Treatment Trialists' Collaboration None., (2022), Clin Trials

Design, recruitment, and baseline characteristics of the EMPA-KIDNEY trial.

EMPA-KIDNEY Collaborative Group None., (2022), Nephrol Dial Transplant, 37, 1317 - 1329

Beyond Ten-Year Risk: A Cost-Effectiveness Analysis of Statins for the Primary Prevention of Cardiovascular Disease

Kohli-Lynch CN. et al, (2022), Circulation

The effect of fenofibrate therapy on laser treatment for diabetic retinopathy: a meta-analysis of randomized trials

Preiss D. et al, (2022), DIABETES RESEARCH AND CLINICAL PRACTICE, 186

Impact of ACLY on type 2 diabetes in UK Biobank: a Mendelian randomisation study

Stiby A. et al, (2021), EUROPEAN HEART JOURNAL, 42, 3011 - 3011

The effect of fenofibrate therapy on laser treatment for diabetic retinopathy: a meta-analysis of randomized controlled trials

PREISS D. et al, (2021), Diabetes Care

Determinants of statin initiation and discontinuation in the secondary prevention of atherosclerotic cardiovascular disease in Scotland during 2009-2017

Thalmann I. et al, (2020), EUROPEAN HEART JOURNAL, 41, 3509 - 3509

Erratum: The potential for improving cardio-renal outcomes by sodium-glucose co-transporter-2 inhibition in people with chronic kidney disease: a rationale for the EMPA-KIDNEY study.

Herrington WG. et al, (2020), Clin Kidney J, 13

Carotid intima-media thickness progression as surrogate marker for cardiovascular risk: Meta-analysis of 119 clinical trials involving 100,667 patients

PREISS D., (2020), Circulation

Lipid-Modifying Agents, From Statins to PCSK9 Inhibitors: JACC Focus Seminar.

Preiss D. et al, (2020), J Am Coll Cardiol, 75, 1945 - 1955

Publisher Correction: GDF15 mediates the effects of metformin on body weight and energy balance.

Coll AP. et al, (2020), Nature, 578

GDF15 mediates the effects of metformin on body weight and energy balance

PREISS D., (2019), Nature

CV Care: Lipid-modifying Agents--From Statins to PCSK9 inhibitors

PREISS D. and REITH C., (2019), JACC - Journal of the American College of Cardiology

Research digest: new horizons in heart failure therapy.

Sattar N. and Preiss D., (2019), The lancet. Diabetes & endocrinology, 7

Cookies on this website

Publications